UNSPSC 85533067: Supplement left renal vein with nonautologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left renal vein with nonautologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 06UB3KZ

UNSPSC 85533067 Supplement left renal vein with nonautologous tissue substitute, percutaneous approach is a Commodity code that shows no relevant recent state and local procurement activity. The six most recent opportunities tagged under this code involve independent medical evaluation services for disability benefit determinations, surgical benefit carve-out programs, occupational medical surveillance, specialty and emergency medical services for detained youth, pharmacy benefit management, and temporary health professional staffing — none of which involve vascular surgical procedures, tissue substitutes, or the specific clinical intervention the code describes. The mismatch between the code's nominal scope and actual procurement content suggests either systematic miscoding in the source data or that state and local agencies rarely or never procure this particular vascular procedure through open solicitation. State and local health systems and public employee benefit programs appear to manage such specialized surgical services through existing hospital networks, group purchasing agreements, or direct clinical protocols rather than standalone procurement vehicles.

Without solicitations that align with the code's stated scope, no representative opportunities, issuing-body mix, or geographic concentration can be credibly characterized. Business development professionals should confirm whether similar vascular procedure codes or broader surgical-service codes are more actively solicited before committing resources to track this commodity.